A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/70 (2006.01) C07K 16/18 (2006.01) C12Q 1/32 (2006.01) G01N 33/53 (2006.01) G01N 33/66 (2006.01) G01N 33/74 (2006.01)
Patent
CA 2264829
The diagnosis of diabetes based on the level or ratio of P- and A-type inositolphosphoglycans (IPGs) in a sample from a patient, and the use of P- and A-type IPGs or their antagonists in the treatment of diabetes is disclosed. In particular, the present invention provides treatment of IDDM or lean type II diabetes (NIDDM) with a mixture of P- and A-type mediators, and treatment of obese type II diabetes (NIDDM) with a P-type mediator and/or an A- type antagonist.
Diagnostic du diabète basé sur le taux ou le rapport d'inositolphosphoglycannes (IPG) de type P et A dans le prélèvement provenant d'un patient et utilisation des IPG de type P et A ou de leurs antagonistes dans le traitement du diabète. En particulier, la présente invention concerne le traitement du diabète insulinodépendant ou du diabète maigre non insulinodépendant à l'aide d'un mélange de médiateurs de type P et A, ainsi que le traitement du diabète gras non insulinodépendant à l'aide d'un médiateur de type P et/ou d'un antagoniste de type A.
Mclean Patricia
Rademacher Thomas William
Bereskin & Parr
Rademacher Group Limited
Rodaris Pharmaceuticals Limited
LandOfFree
Materials and methods relating to the diagnosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods relating to the diagnosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods relating to the diagnosis and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1412153